Sitagliptin (DPP-4 inhibitor)-induced rheumatoid arthritis in type 2 diabetes mellitus: a case report

MLA

Kazuki Yokota, and Naoya Igaki. “Sitagliptin (DPP-4 Inhibitor)-Induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report.” Internal Medicine (Tokyo, Japan), vol. 51, no. 15, Aug. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....324d82b0c6e55bd9a9dad373e43e0c93&authtype=sso&custid=ns315887.

APA

Kazuki Yokota, & Naoya Igaki. (2012). Sitagliptin (DPP-4 inhibitor)-induced rheumatoid arthritis in type 2 diabetes mellitus: a case report. Internal Medicine (Tokyo, Japan), 51(15).

Chicago

Kazuki Yokota, and Naoya Igaki. 2012. “Sitagliptin (DPP-4 Inhibitor)-Induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report.” Internal Medicine (Tokyo, Japan) 51 (15). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....324d82b0c6e55bd9a9dad373e43e0c93&authtype=sso&custid=ns315887.